126 related articles for article (PubMed ID: 31607016)
1. [Drug therapy of high grade osteosarcoma].
Ye T; Zhang JY; Chen J
Zhonghua Yi Xue Za Zhi; 2019 Oct; 99(37):2893-2896. PubMed ID: 31607016
[TBL] [Abstract][Full Text] [Related]
2. [Osteogenic osteosarcoma and drug therapy. Study in vitro of osteosarcoma's sensitivity to drugs. Therapeutic applications].
Morasca L; Roy-Camille R; Pouliquen JC
Chirurgie; 1970; 96(1):53-62. PubMed ID: 5279883
[No Abstract] [Full Text] [Related]
3. Osteosarcoma: the state of affairs dictates a change. What do we know?
Kleinerman ES; Mary V; John A
Adv Exp Med Biol; 2014; 804():vii-viii. PubMed ID: 25207354
[No Abstract] [Full Text] [Related]
4. [Determination of the degree of morphological regression following chemotherapy in malignant bone tumors].
Salzer-Kuntschik M; Brand G; Delling G
Pathologe; 1983 May; 4(3):135-41. PubMed ID: 6576329
[No Abstract] [Full Text] [Related]
5. [A rapid colorimetric assay for viability of osteosarcoma cells after chemotherapy].
Chen Q; Zhang JH; Chen JT; Shi ZJ; Deng YJ
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Dec; 29(12):2490-1. PubMed ID: 20034909
[TBL] [Abstract][Full Text] [Related]
6. Osteosarcoma of the pelvis treated successfully with repetitive intra-arterial chemotherapy and radiation therapy: a report of a case with a 21-year follow-up.
Katagiri H; Sugiyama H; Takahashi M; Murata H; Wasa J; Hosaka S; Miyagi M
J Orthop Sci; 2015 May; 20(3):568-73. PubMed ID: 24357190
[No Abstract] [Full Text] [Related]
7. Emerging drugs for high-grade osteosarcoma.
Hattinger CM; Pasello M; Ferrari S; Picci P; Serra M
Expert Opin Emerg Drugs; 2010 Dec; 15(4):615-34. PubMed ID: 20690888
[TBL] [Abstract][Full Text] [Related]
8. Research progress on the multidrug resistance mechanisms of osteosarcoma chemotherapy and reversal.
Li S; Sun W; Wang H; Zuo D; Hua Y; Cai Z
Tumour Biol; 2015 Mar; 36(3):1329-38. PubMed ID: 25666750
[TBL] [Abstract][Full Text] [Related]
9. Osteosarcoma. Specimen management following primary chemotherapy.
Raymond AK; Simms W; Ayala AG
Hematol Oncol Clin North Am; 1995 Aug; 9(4):841-67. PubMed ID: 7490245
[TBL] [Abstract][Full Text] [Related]
10. Imprinting defects in osteosarcoma: DNA- and chromatin-modifying drugs hold promise for osteosarcoma therapy.
Sarver AE; Subramanian S
Epigenomics; 2016 Jul; 8(7):885-8. PubMed ID: 27366930
[No Abstract] [Full Text] [Related]
11. Morphological grades of regression in osteosarcoma after polychemotherapy - study COSS 80.
Salzer-Kuntschik M; Delling G; Beron G; Sigmund R
J Cancer Res Clin Oncol; 1983; 106 Suppl():21-4. PubMed ID: 6577010
[TBL] [Abstract][Full Text] [Related]
12. Practical approach to processing osteosarcomas in the surgical pathology laboratory.
Wold LE
Pediatr Dev Pathol; 1998; 1(5):449-54. PubMed ID: 9688771
[No Abstract] [Full Text] [Related]
13. How far can we go with surgery in metastatic osteosarcoma patients?
Meazza C; Scanagatta P; Luksch R; Massimino M
Med Oncol; 2015 Sep; 32(9):223. PubMed ID: 26208650
[No Abstract] [Full Text] [Related]
14. Primary chondroblastic osteogenic sarcoma of the clavicle: a rare occurrence.
Gupta R; Arora R; Sharma A; Dinda AK
Pathology; 2009; 41(4):408-10. PubMed ID: 19404863
[No Abstract] [Full Text] [Related]
15. Advances in differentiation therapy for osteosarcoma.
Chen Y; Cao J; Zhang N; Yang B; He Q; Shao X; Ying M
Drug Discov Today; 2020 Mar; 25(3):497-504. PubMed ID: 31499188
[TBL] [Abstract][Full Text] [Related]
16. Is it ethical not to conduct a prospectively controlled trial of adjuvant chemotherapy in osteosarcoma?
Lange B; Levine AS
Cancer Treat Rep; 1982 Sep; 66(9):1699-704. PubMed ID: 6749284
[No Abstract] [Full Text] [Related]
17. Cancer stem cells in osteosarcoma.
Brown HK; Tellez-Gabriel M; Heymann D
Cancer Lett; 2017 Feb; 386():189-195. PubMed ID: 27894960
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant therapy in the management of osteosarcoma: need for critical reassessment.
Breur K; van der Schueren E
Recent Results Cancer Res; 1978; 68():5-15. PubMed ID: 288110
[No Abstract] [Full Text] [Related]
19. Role of pharmacogenetics of drug-metabolizing enzymes in treating osteosarcoma.
Hattinger CM; Serra M
Expert Opin Drug Metab Toxicol; 2015; 11(9):1449-63. PubMed ID: 26095223
[TBL] [Abstract][Full Text] [Related]
20. Can pharmacogenomics help to improve therapy in patients with high-grade osteosarcoma?
Kager L; Diakos C; Bielack S
Expert Opin Drug Metab Toxicol; 2015 Jul; 11(7):1025-8. PubMed ID: 25882838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
